{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:41:04Z","timestamp":1790959264034,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81270880"],"award-info":[{"award-number":["81270880"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Chinese Ministry of Science and Technology","doi-asserted-by":"publisher","award":["2009CB521902"],"award-info":[{"award-number":["2009CB521902"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.gene.2015.12.007","type":"journal-article","created":{"date-parts":[[2015,12,12]],"date-time":"2015-12-12T17:16:01Z","timestamp":1449940561000},"page":"85-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Overexpression of the BRIP1 ameliorates chemosensitivity to cisplatin by inhibiting Rac1 GTPase activity in cervical carcinoma HeLa cells"],"prefix":"10.1016","volume":"578","author":[{"given":"Yu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongtong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2015.12.007_bb0005","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1093\/annonc\/mdr015","article-title":"Worldwide burden of cervical cancer in 2008","volume":"22","author":"Arbyn","year":"2011","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.gene.2015.12.007_bb0010","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/1471-2407-14-246","article-title":"Gene expression profiling reveals activation of the FA\/BRCA pathway in advanced squamous cervical cancer with intrinsic resistance and therapy failure","volume":"14","author":"Balacescu","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.gene.2015.12.007_bb0015","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1158\/1535-7163.MCT-13-0164","article-title":"RAC1: an emerging therapeutic option for targeting cancer angiogenesis and metastasis","volume":"12","author":"Bid","year":"2013","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.gene.2015.12.007_bb0020","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1042\/bj3480241","article-title":"Rho GTPases and their effector proteins","volume":"348 Pt 2","author":"Bishop","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.gene.2015.12.007_bb0025","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/bies.20558","article-title":"GTP-binding proteins of the Rho\/Rac family: regulation, effectors and functions in vivo","volume":"29","author":"Bustelo","year":"2007","journal-title":"BioEssays"},{"key":"10.1016\/j.gene.2015.12.007_bb0030","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0092-8674(01)00304-X","article-title":"BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function","volume":"105","author":"Cantor","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.gene.2015.12.007_bb0035","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1073\/pnas.0308717101","article-title":"The BRCA1-associated protein BACH1 is a DNA helicase targeted by clinically relevant inactivating mutations","volume":"101","author":"Cantor","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.gene.2015.12.007_bb0040","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1158\/0008-5472.CAN-06-4433","article-title":"Metallothionein expression is suppressed in primary human hepatocellular carcinomas and is mediated through inactivation of CCAAT\/enhancer binding protein alpha by phosphatidylinositol 3-kinase signaling cascade","volume":"67","author":"Datta","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.gene.2015.12.007_bb0045","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/nrm2476","article-title":"Mammalian Rho GTPases: new insights into their functions from in vivo studies","volume":"9","author":"Heasman","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.gene.2015.12.007_bb0050","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1182\/blood-2013-08-523563","article-title":"Tiam1\/Rac1 signals contribute to the proliferation and chemoresistance, but not motility, of chronic lymphocytic leukemia cells","volume":"123","author":"Hofbauer","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.gene.2015.12.007_bb0055","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.gene.2015.12.007_bb0060","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/sj.bjc.6604847","article-title":"A recurrent truncating germline mutation in the BRIP1\/FANCJ gene and susceptibility to prostate cancer","volume":"100","author":"Kote-Jarai","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.gene.2015.12.007_bb0065","first-page":"3447","article-title":"HeLa human cervical cancer cell migration is inhibited by treatment with dibutyryl-cAMP","volume":"34","author":"Lee","year":"2014","journal-title":"Anticancer Res."},{"key":"10.1016\/j.gene.2015.12.007_bb0070","first-page":"261","article-title":"Intrinsic and acquired drug resistance in malignant tumors. The main reason for therapeutic failure","volume":"58","author":"Lippert","year":"2008","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.gene.2015.12.007_bb0075","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.gene.2015.12.007_bb0080","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.bbrc.2013.02.089","article-title":"BRIP1 variations analysis reveals their relative importance as genetic susceptibility factor for cervical cancer","volume":"433","author":"Ma","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.gene.2015.12.007_bb0085","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.gene.2013.04.025","article-title":"First evidence for the contribution of the genetic variations of BRCA1-interacting protein 1 (BRIP1) to the genetic susceptibility of cervical cancer","volume":"524","author":"Ma","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.gene.2015.12.007_bb0090","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1002\/cncr.24364","article-title":"Novel chemotherapy approaches for cervical cancer","volume":"115","author":"Movva","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.gene.2015.12.007_bb0095","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1038\/sj.onc.1209257","article-title":"BACH1 is a DNA repair protein supporting BRCA1 damage response","volume":"25","author":"Peng","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.gene.2015.12.007_bb0100","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/GCO.0b013e3283630d6a","article-title":"The surgical management of early-stage cervical cancer","volume":"25","author":"Salicru","year":"2013","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"10.1016\/j.gene.2015.12.007_bb0105","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/jnci\/djq562","article-title":"Human papillomavirus testing in the prevention of cervical cancer","volume":"103","author":"Schiffman","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.gene.2015.12.007_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000268","article-title":"Tagging single nucleotide polymorphisms in the BRIP1 gene and susceptibility to breast and ovarian cancer","volume":"2","author":"Song","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2015.12.007_bb0115","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/j.ygyno.2008.04.024","article-title":"Chemotherapy for recurrent and metastatic cervical cancer","volume":"110","author":"Tao","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gene.2015.12.007_bb0120","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.devcel.2011.10.010","article-title":"Oncogenic RAS regulates BRIP1 expression to induce dissociation of BRCA1 from chromatin, inhibit DNA repair, and promote senescence","volume":"21","author":"Tu","year":"2011","journal-title":"Dev. Cell"},{"key":"10.1016\/j.gene.2015.12.007_bb0125","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10456-011-9229-x","article-title":"Examining the role of Rac1 in tumor angiogenesis and growth: a clinically relevant RNAi-mediated approach","volume":"14","author":"Vader","year":"2011","journal-title":"Angiogenesis"},{"key":"10.1016\/j.gene.2015.12.007_bb0130","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/j.1525-1438.2007.01129.x","article-title":"ESGO statement on cervical cancer vaccination","volume":"17","author":"Vergote","year":"2007","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.gene.2015.12.007_bb0135","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/1471-2407-11-271","article-title":"Zinc finger protein ZBTB20 expression is increased in hepatocellular carcinoma and associated with poor prognosis","volume":"11","author":"Wang","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.gene.2015.12.007_bb0140","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.molonc.2013.05.001","article-title":"Activation of Rac1 GTPase promotes leukemia cell chemotherapy resistance, quiescence and niche interaction","volume":"7","author":"Wang","year":"2013","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.gene.2015.12.007_bb0145","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s10549-011-1443-0","article-title":"BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer","volume":"127","author":"Wong","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.gene.2015.12.007_bb0150","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1177\/0300060513479875","article-title":"Effect of Rac1 downregulation mediated by shRNA on the biological behaviour of human cervical cancer cells","volume":"41","author":"Xu","year":"2013","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.gene.2015.12.007_bb0155","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/aps.2011.116","article-title":"Anti-tumor activity of CrTX in human lung adenocarcinoma cell line A549","volume":"32","author":"Ye","year":"2011","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.gene.2015.12.007_bb0160","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1126\/science.1088753","article-title":"The BRCT domain is a phospho-protein binding domain","volume":"302","author":"Yu","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.gene.2015.12.007_bb0165","first-page":"61","article-title":"Inhibition of epidermal growth factor receptor expression by RNA interference in A549 cells","volume":"25","author":"Zhang","year":"2004","journal-title":"Acta Pharmacol. Sin."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037811191501478X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037811191501478X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T22:28:54Z","timestamp":1537136934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037811191501478X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S037811191501478X"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2015.12.007","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overexpression of the BRIP1 ameliorates chemosensitivity to cisplatin by inhibiting Rac1 GTPase activity in cervical carcinoma HeLa cells","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2015.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}